• Wildcard: BICO, Bioprinting, and Bioconvergence

  • Dec 15 2021
  • Duración: 26 m
  • Podcast

Wildcard: BICO, Bioprinting, and Bioconvergence

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • We get back to Wednesday's healthcare roots with a rundown on BICO Group, a Sweden-based business that enables researchers and scientists to model, build, test, analyze and observe 3-D printed cells, tissues and organs.

    This company helps researchers reduce the time and cost of identifying potentially efficacious drugs and can help provide initial results on whether drug compounds are safe and effective before having to test them on animals or humans.

    We talk through the huge implications it could have for research in life sciences and personalized medicine and try to clear up some of the jargon around the company.

    Stocks: (OM:BICO)

    Check out more of our content here:

    Podcasts

    Youtube

    Twitter

    Reach us by Email @ IndustryFocus@fool.com
    Más Menos
activate_WEBCRO358_DT_T2
Más Menos

Lo que los oyentes dicen sobre Wildcard: BICO, Bioprinting, and Bioconvergence

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles